Fosaprepitant
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB06717 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 100 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | nephrogenic syndrome of inappropriate antidiuresis | KG + DL |
| 2 | pneumocystosis | KG + DL |
| 3 | leprosy | KG + DL |
| 4 | Cryptococcal meningitis | KG + DL |
| 5 | multiple endocrine neoplasia | KG + DL |
| 6 | intracranial abscess | KG + DL |
| 7 | retinitis | KG + DL |
| 8 | Plasmodium falciparum malaria | KG + DL |
| 9 | echinococcus granulosus infectious disease | KG + DL |
| 10 | hyperargininemia | KG + DL |
| 11 | hypertrichosis (disease) | KG + DL |
| 12 | cysticercosis | KG + DL |
| 13 | acute neonatal citrullinemia type I | KG + DL |
| 14 | adult-onset citrullinemia type I | KG + DL |
| 15 | malaria | KG + DL |
| 16 | persistent Mullerian duct syndrome | KG + DL |
| 17 | HIV infectious disease | KG + DL |
| 18 | syndrome with a Dandy-Walker malformation as major feature | KG + DL |
| 19 | motor nerve neuritis | KG + DL |
| 20 | malformation syndrome with odontal and/or periodontal component | KG + DL |
| 21 | Ambras type hypertrichosis universalis congenita | KG + DL |
| 22 | rheumatoid arthritis | KG + DL |
| 23 | isolated genetic hair shaft abnormality | KG + DL |
| 24 | alveolar echinococcosis | KG + DL |
| 25 | vestibular neuronitis | KG + DL |
| 26 | urea cycle disorder | KG + DL |
| 27 | pulmonary hypertension | KG + DL |
| 28 | brachial plexus neuritis | KG + DL |
| 29 | scleroderma (disease) | KG + DL |
| 30 | coenurosis | KG + DL |
| 31 | neuroretinitis | KG + DL |
| 32 | arteriosclerosis disorder | KG + DL |
| 33 | Bacteroidaceae infectious disease | KG + DL |
| 34 | kyphoscoliotic heart disease | KG + DL |
| 35 | nephrogenic diabetes insipidus | KG + DL |
| 36 | facial nerve palsy due to herpes zoster infection | KG + DL |
| 37 | hypoalphalipoproteinemia | KG + DL |
| 38 | myiasis | KG + DL |
| 39 | subarachnoid hemorrhage (disease) | KG + DL |
| 40 | neurodevelopmental disorder with ataxic gait, absent speech, and decreased cortical white matter | KG + DL |
| 41 | simian immunodeficiency virus infection | KG + DL |
| 42 | feline acquired immunodeficiency syndrome | KG + DL |
| 43 | brachydactyly-syndactyly syndrome | KG + DL |
| 44 | cerebral atherosclerosis | KG + DL |
| 45 | generalized atherosclerosis | KG + DL |
| 46 | opisthorchiasis | KG + DL |
| 47 | Cestode infectious disease | KG + DL |
| 48 | wound myiasis | KG + DL |
| 49 | creeping myiasis | KG + DL |
| 50 | furuncular myiasis | KG + DL |
(Showing top 50 of 100 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.